+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients

Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients

Pathology, Research and Practice 212(9): 804-810

High-risk human papillomavirus (HR-HPV) infections were the causal factor in the development of cervical cancer, but the significance of HPV viral load in the prediction of the response to current therapeutic approaches had not reached consensus. The present study was performed to assess the high risk HPV viral load of cervical cancer patients who underwent radiotherapy alone or in combination with chemotherapy or hyperthermotherapy or both in correlation to long-term survival. 116 cervical cancer patients were recruited and assigned into four groups of different therapeutic modalities. The prevalent high risk types of HPV 16, 18, 58 were detected by type specific in situ hybridization (ISH), and HPV mRNA was detected by RNA scope assay using RNA scope 2.0 FFPE Reagent Kit. Semi-quantification of the HR-HPV viral load was measured based on the intensity of ISH signal captured from the tumor nests in the grey scale. The HR-HPV viral load had a significant negative correlation with survival (rs=-0.368, P=0.001). The 15-year survival rate of low viral load group was 68.18%, moderate viral load group was 52.17%, and high viral load group was 34.69% (P=0.001). HPV mRNA expression was strongly consistent with HPV viral load. The 15-year survival rates of different therapeutic groups were 39.29%, 58.62%, 50.00%, 55.17%, respectively (P=0.545). Combinatorial treatment modalities improved the actual survival, which demonstrated no significant difference among 5, 10 and 15 years comparison. Cox regression analysis showed that the relative risk of death was obviously higher in the HPV 18 single positive group and high HPV viral load group. The semi-quantitive viral load assessment in situ is a feasible approach in clinical practice. The more the HPV viral load was, the worse the survival of patients would be. The combinational treatments were in favor of the disease-stabilization.

(PDF emailed within 0-6 h: $19.90)

Accession: 058637140

Download citation: RISBibTeXText

PMID: 27461827

DOI: 10.1016/j.prp.2016.06.011

Related references

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance. Zentralblatt für Gynakologie 123(2): 91-101, 2001

High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clinical Cancer Research 13(1): 132-138, 2007

Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population. Genetics and Molecular Research 11(4): 4720-4727, 2013

The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. American Journal of Obstetrics and Gynecology 201(1): 79.E1-7, 2009

Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360(9328): 228-229, 2002

Detection and estimation of human papillomavirus viral load in patients with cervical lesions. Bangladesh Medical Research Council Bulletin 39(2): 86-90, 2014

Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal. Cancer Epidemiology 38(4): 369-375, 2015

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiology, Biomarkers & Prevention 14(5): 1311-1314, 2005

Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions. Zhonghua Yi Xue Za Zhi 91(13): 906-910, 2011

Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecologic Oncology 29(3): 267-273, 1988

Prognostic significance of human papillomavirus type 16 and 18 in cervical cancer. Seoul Journal of Medicine 36(2): 53-60, 1995

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening. Journal of Lower Genital Tract Disease 21(1): 12-16, 2016

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer. Cancer (Philadelphia) 74(8): 2307-2313, 1994

Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery. Journal of Gynecologic Oncology 26(2): 111-117, 2016